McKesson (MCK) Stock Declines While Market Improves: Some Information for Investors

Company Performance - McKesson's stock closed at $586.08, reflecting a -1.1% change from the previous day, underperforming the S&P 500's gain of 0.88% [1] - Over the past month, McKesson's stock has increased by 2.74%, while the Medical sector has seen a loss of 0.32% and the S&P 500 has gained 1.17% [1] Upcoming Earnings - McKesson's earnings report is anticipated on February 5, 2025, with projected earnings per share (EPS) of$ 8.28, indicating a 6.98% increase from the same quarter last year [2] - Revenue is expected to reach $95.46 billion, reflecting an 18% growth compared to the same quarter of the previous year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at$ 32.73 per share and revenue at $358.91 billion, representing increases of +19.28% and +16.17% respectively from the prior year [3] Analyst Estimates - Recent changes to analyst estimates for McKesson are significant as they reflect the evolving business trends, with positive revisions indicating analysts' confidence in the company's performance [4] - The Zacks Rank system, which evaluates estimate changes, currently ranks McKesson at 3 (Hold) [6] Valuation Metrics - McKesson has a Forward P/E ratio of 18.11, which aligns with its industry's Forward P/E of 18.11, indicating no significant deviation [7] - The company holds a PEG ratio of 1.28, compared to the average PEG ratio of 2 for the Medical - Dental Supplies industry [8] Industry Context - The Medical - Dental Supplies industry, part of the Medical sector, has a Zacks Industry Rank of 150, placing it in the bottom 41% of over 250 industries [9]